Difference between revisions of "Medroxyprogesterone acetate (MPA)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m |
m |
||
| Line 1: | Line 1: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Endometrial cancer]] | *[[Endometrial cancer]] | ||
| + | |||
| + | ==Diseases for which it was used== | ||
| + | *[[Breast cancer - historical|Breast cancer]] | ||
| + | *[[Renal cell carcinoma - historical|Renal cell carcinoma]] | ||
==Also known as== | ==Also known as== | ||
| Line 14: | Line 18: | ||
[[Category:Endometrial cancer medications]] | [[Category:Endometrial cancer medications]] | ||
| + | |||
| + | [[Category:Breast cancer medications (historic)]] | ||
| + | [[Category:Renal cell carcinoma medications (historic)]] | ||
[[Category:FDA approved in 1959]] | [[Category:FDA approved in 1959]] | ||
| + | |||
| + | [[Category:Stub]] | ||
Revision as of 12:02, 28 April 2022
Diseases for which it is used
Diseases for which it was used
Also known as
- Generic names: medroxyprogesterone acetate, MPA
- Brand names: Depo-Provera, Provera